Arthneeti

Uniphos Enterprises Share Price & Earnings Call Analysis

₹88.81+2.60% today
Market cap
₹618 Cr
P/E
30.49
ROE
0.80%
PEG
-1.66
Price to sales
23.63
Debt to equity
0.00
52W high / low
₹156 / ₹81.5
Sales growth (5Y)
107.59%
EBITDA margin
-15.61%
Net profit margin
64.72%
Promoter holding
73.79%
Sales (last year)
₹26 Cr

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Uniphos Enterprises rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Sign up free to see every company in the sector ranking and track Uniphos Enterprises.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Uniphos Enterprises

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Uniphos Enterprises

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +0.000.000.000.0050.653.0330.485.1072.905.860.000.0026.14
Expenses +0.730.790.750.6951.513.7830.966.1074.506.701.100.9726.96
Operating Profit-0.73-0.79-0.75-0.69-0.86-0.75-0.48-1.00-1.60-0.84-1.10-0.97-0.82
OPM %-1.70%-24.75%-1.57%-19.61%-2.19%-14.33%-3.14%
Other Income +1.150.9140.440.870.650.794.670.450.210.2724.430.130.40
Interest0.000.000.000.000.000.000.141.170.000.000.000.000.00
Depreciation0.220.210.210.210.210.190.190.190.190.170.170.170.17
Profit before tax0.20-0.0939.48-0.03-0.42-0.153.86-1.91-1.58-0.7423.16-1.01-0.59
Tax %-135.00%0.00%0.30%0.00%50.00%0.00%0.00%-2.62%0.00%0.00%0.00%0.00%18.64%
Net Profit +0.47-0.0839.36-0.03-0.63-0.153.86-1.86-1.58-0.7423.16-1.01-0.70
EPS in Rs0.07-0.015.66-0.00-0.09-0.020.56-0.27-0.23-0.113.33-0.15-0.10

Financials of Uniphos Enterprises

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +2000001115111232
Expenses +3122324445411536
Operating Profit-1-1-2-2-3-2-3-3-3-3-4-4
OPM %-47%-987%-370%-257%-195%-6%-3%-12%
Other Income +11141320242326574343625
Interest100000000010
Depreciation000000001111
Profit before tax9121118212023544039021
Tax %0%0%0%2%2%2%-4%-1%1%1%-22%1%
Net Profit +9121118212024553939021
EPS in Rs1.231.701.622.542.992.893.527.855.645.550.042.98
Dividend Payout %0%0%0%0%0%0%97%72%115%103%1,242%118%

Financials of Uniphos Enterprises

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital141414141414141414141414
Reserves2582702,0532,0762,6841,5042,7013,1672,9842,0622,7282,433
Borrowings +1000000000001
Other Liabilities +00000157121982100171
Total Liabilities2822842,0672,0902,6981,5192,7723,3023,0952,0782,8422,619
Fixed Assets +174174175175175175176176184183182182
CWIP000000000000
Investments84841,8561,8712,4831,2612,5503,0802,8561,8022,6162,372
Other Assets +242636444083464655924465
Total Assets2822842,0672,0902,6981,5192,7723,3023,0952,0782,8422,619

Financials of Uniphos Enterprises

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-8-2-2-3-3-2-51-1-3-3
Cash from Investing Activity +1014-09-244-3420415053
Cash from Financing Activity +-1-1100000-24-39-45-41
Net Cash Flow11-25-542-38-3-019
Free Cash Flow-8-2-2-3-3-2-51-1-3-3
CFO/OP870%93%105%109%93%77%117%91%90%90%66%

Financials of Uniphos Enterprises

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days0000030298
Inventory Days00000000
Days Payable
Cash Conversion Cycle0000030298
Working Capital Days-1,98224,7726,6804,43417-11-637
ROCE %3%4%1%1%1%1%1%2%1%1%0%1%
10out of 100

Momentum score · price trend

10 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−41.6%10%
Last 6 months−19.2%22%
Last 3 months−10.8%42%

The price is 53.4% below its all-time high of ₹185.9 (6 Sept 2024). Stocks more than 20% below their peak have their score halved, so 21 became 10.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Uniphos Enterprises: 0.4 × 10 + 0.4 × 22 + 0.2 × 42 = 21, halved to 10 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF